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Abstract: 
The present study examined the psychometric properties of the Schizotypal Ambivalence Scale 
(SAS) in a sample of 1798 young adults. The study also investigated the concurrent validity of 
the measure for identifying schizophrenic-like symptoms in a sample of 43 high scorers on the 
scale and 43 control participants. Previous findings indicated that high scores on the SAS were 
associated with schizophrenia-spectrum pathology in a sample of schizotypic young adults 
selected with other measures. However, this is the first study to assess schizophrenic-like 
psychopathology in a sample selected using the SAS. The SAS has good internal consistency 
(coefficient [alpha] = 0.84) and test-retest reliability (intraclass correlation = 0.74 across 9 
weeks). As hypothesized, the ambivalence group exceeded the control group on interview ratings 
of schizotypal, schizoid, paranoid, psychotic-like, and negative symptoms, as well as exhibiting 
poorer overall functioning. The SAS seems to be a promising measure of schizotypy in young 
adults. 
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Article: 
The present study examined the psychometric properties and concurrent validity of the 
Schizotypal Ambivalence Scale (SAS; Raulin, 1986) for identifying schizophrenic-like 
symptoms and other forms of psychopathology in a sample of college students. The study built 
upon (Kwapil et al., 2002) preliminary findings for the scale by providing norms and reliability 
estimates for a large college student sample, examining the relationship of the scale with other 
psychometric indicators of schizotypy, and examining the concurrent validity of the scale for 
identifying schizotypy. 
 
Ambivalence, Schizotypy, and Schizophrenia 
 The term ambivalence was coined by Bleuler (1911/1950) to describe the “tendency of the 
schizophrenic psyche to endow the most diverse psychisms with both a positive and negative 
indicator at 1 and the same time” (p. 53) (e.g., simultaneously experiencing intense love and 
hatred for a person). Bleuler hypothesized that ambivalence was 1 of 4 fundamental symptoms of 
schizophrenia—symptoms that he argued were always present in the disorder. Likewise, Meehl 
(1962) described ambivalence as 1 of the 4 core symptoms of schizotypy (the latent personality 
organization found in those individuals at genetic risk for schizophrenia). However, in later 
writings, Meehl (1989, 1990) assigned ambivalence a secondary role as a potentiating factor in 
schizotypy—that is, a factor that increases risk for deterioration in those people who have 
specific risk factors for schizophrenia. 
Despite the prominent role of ambivalence in both Bleuler's formulation of schizophrenia and 
Meehl's initial model of schizotypy, the construct received little attention from developmental 
and experimental psychopathologists studying schizotypy and schizophrenia. The lack of 
research resulted in large part from a failure to adequately operationalize the construct, as well as 
a gradual modification of the construct by psychoanalytic theorists studying borderline 
personality (e.g., Kernberg, 1977; see Raulin and Brenner, 1993, for a review). However, recent 
studies have attempted to operationalize ambivalence and assess its relationship with schizotypy 
and schizophrenia, defining ambivalence based largely on Bleuler and Meehl's formulations. 
  
Psychometric Assessment of Ambivalence 
 Several studies have examined the relationship of ambivalence with schizophrenic-like 
psychopathology in clinical and nonclinical samples. Raulin (1984) developed the 45-item 
Intense Ambivalence Scale as part of a larger effort to develop psychometric inventories for 
screening adolescents and young adults at risk for schizophrenia. This initial scale was based on 
the description of intense ambivalence provided by Meehl (1964) in his Checklist of Schizotypic 
Signs. Raulin (1984) found that patients with schizophrenia scored significantly higher on the 
scale than nonpatient control participants, but not significantly higher than a group of 
heterogeneous outpatient clinic clients. Furthermore, depressed inpatients scored significantly 
higher on the scale than patients with schizophrenia. Kwapil et al. (2000) examined the 
predictive validity of the Intense Ambivalence Scale in a subset of schizotypic and control 
participants from Chapman et al.'s (1994) 10-year longitudinal study. The schizotypic 
participants were identified by deviantly high scores on the perceptual aberration (Chapman et 
al., 1978) and the magical ideation (Eckblad and Chapman, 1983) scales. Elevated scores on the 
Intense Ambivalence Scale predicted psychotic-like, schizotypal, and depressive symptoms, 
substance abuse, and the development of psychotic illness at the 10-year follow-up assessment, 
even after the removal of variance for membership in the schizotypy and control groups. 
  
Because the original Intense Ambivalence Scale proved to be especially sensitive to depressive 
symptomatology, instead of specific to the ambivalence thought to be characteristic of 
schizophrenia and schizotypy, Raulin (1986) developed a second ambivalence scale referred to 
as the SAS. This scale included a subset of items from the original scale that differentiated 
schizophrenic patients from controls and from psychotically depressed patients. Kwapil et al. 
(2002) provided a preliminary examination of the psychometric properties and concurrent 
validity of the SAS. They conducted diagnostic interviews with a sample of 131 college students 
identified by deviantly high scores on the perceptual aberration and magical ideation scales and 
control participants. In this sample, elevated scores on the SAS were associated with schizotypal, 
schizoid, and paranoid symptoms, as well as poorer overall functioning (after the removal of 
variance associated with perceptual aberration/magical ideation and control group membership). 
Unlike the findings for the Intense Ambivalence Scale, the revised scale was not associated with 
elevated rates of mood disorders or ratings of substance use or abuse. These findings suggested 
that the SAS might be a more promising measure for identifying ambivalence that is specifically 
associated with schizophrenia and schizotypy. However, the findings of Kwapil et al. (2002) 
were limited by the fact that the participants were selected based upon scores on other schizotypy 
questionnaires. 
  
Goals and Hypotheses of the Present Study 
 The present study extended the preliminary findings of Kwapil et al. (2002) by examining the 
psychometric properties of the SAS, including internal consistency and test-retest reliability in a 
large sample of college students. The study also assessed the concurrent validity of the SAS in a 
sample of high scorers on the scale and control participants. Unlike Kwapil et al. (2002), the 
present study examined concurrent validity of the scale in a new sample of ambivalence and 
control participants selected solely on scores on the SAS. It was hypothesized that participants 
selected based on high scores on the SAS would exhibit elevated rates of schizophrenic-like 
symptoms and poorer overall adjustment relative to control participants. 
 
  
METHODS 
Participants 
 Screening packets were completed by 1798 college students enrolled in General Psychology 
courses at the University of North Carolina at Greensboro over the course of 5 semesters. These 
participants included 1057 white females, 354 African American females, 322 white males, and 
65 African American males. A subset of 166 participants (75 white females, 33 African 
American females, 46 white males, and 12 African American males) volunteered to be retested 
on the SAS after an 8- to 11-week interval (M = 9.1 week, SD = 0.9) to examine test-retest 
reliability of the scale. The reassessed participants did not differ from the remaining sample on 
mean score on the SAS at the initial assessment. 
  
Eighty-six participants selected from the latter 3 semesters of mass screening were administered 
a structured diagnostic interview. The interview participants included 43 individuals who 
received standard scores of at least +1.96 on the SAS, and 43 control participants who had 
standard scores of less than +0.5 on the scale [the selection criteria were consistent with the 
recommendations of Chapman et al. (1994)]. Sixteen additional participants (10 from the 
ambivalence and 6 from the control groups) declined to participate in the study or failed to attend 
scheduled appointments. Table 1 lists the demographic characteristics of the interview 
participants. The groups did not differ on any of the demographic characteristics. 
 
 Table 1 
   
 
Materials and Procedure 
Mass-Screening Packet 
The screening packet contained the SAS intermixed with the perceptual aberration, magical 
ideation, revised social anhedonia (Eckblad et al., 1982), and physical anhedonia scales 
(Chapman et al., 1976), and a 13-item infrequency scale (Chapman and Chapman, 1986). The 
students completed the questionnaires in group-testing sessions that lasted approximately 90 
minutes and they received course credit for their participation. Participants who received a score 
of 3 or above on the infrequency scale were omitted from the study. 
 
Schizotypy Scales 
 The SAS contains 19 true-false items that emphasize the simultaneous experience of 
contradictory emotions or the rapid and almost random change of emotions back and forth over 
time. The perceptual aberration scale contains 35 items that assess mild schizophrenic-like 
perceptual and body-image distortions, whereas the magical ideation scale contains 30 items that 
assess belief in experiences that are generally considered implausible or invalid. The revised 
social anhedonia scale contains 40 items that tap schizoid asociality and social disinterest. The 
physical anhedonia scale consists of 61 items that assess deficits in esthetic and sensory 
gratification. Coefficient [alpha] was greater than 0.80 for each of the measures in the present 
sample. 
 
Structured Diagnostic Interview 
 The interview contained the portions of the structured clinical interview for DSM-IV (First et 
al., 1995) that assess mood disorders, substance use, and demographic information. Mood 
episodes were coded as present/absent, whereas substance use and impairment were coded using 
the quantitative rating system described in Kwapil (1996). The modules of the International 
Personality Disorders Examination (World Health Organization, 1995) that assess schizoid, 
paranoid, and schizotypal personality disorders were also included. The Wisconsin manual for 
assessing psychotic-like experiences (Chapman and Chapman, 1980; Kwapil et al., 1999) was 
used to rate psychotic symptoms across a broad range of clinical and subclinical deviancy. The 
negative symptom manual (Kwapil and Dickerson, unpublished data, 2001), which provides a 
companion rating system to the Wisconsin manual, was used to quantify negative symptoms of 
schizophrenia across a range of clinical and subclinical deviances. Each participant's overall 
functioning was rated by the interviewer using the global adjustment scale (GAS; Endicott et al., 
1976), which indicates current functioning with a range from extreme psychopathology to 
superior adjustment. Familial socioeconomic status was rated using Hollingshead's (1957) 2-
factor index of social position. The index of social position is a weighted composite measure of 
occupation and education (with higher scores indicating lower social position). 
 
 A licensed clinical psychologist and 2 advanced undergraduate students with extensive training 
conducted and scored the interviews. The interviewers were unaware of the participants’ group 
membership. Although interrater reliability was not assessed on this sample, reliability data from 
our laboratory are available on several of these measures. Interrater reliability was 0.89 for the 
Wisconsin manual, 0.94 for the negative symptom manual, and 0.87 for the GAS. The diagnostic 
interviews lasted approximately 2 hours and were audiotaped. Students received course credit or 
payment for their participation. 
   
RESULTS 
Psychometric Properties of the SAS 
 The psychometric properties of the SAS were examined for the 1798 participants in the mass-
screening sample (total sample: M = 6.51, SD = 4.36, range = 0–19, coefficient [alpha] = 0.84). 
The distribution of scores was positively skewed and flattened (skew = 0.52; kurtosis = -0.47). 
The positive skew of the distribution resulted from the inclusion of items of relatively low 
endorsement to create a scale that was more discriminating at the high end of the distribution. 
Item-scale correlations for the SAS ranged from 0.43 to 0.57, and item endorsement rates ranged 
from 0.16 to 0.69. Note that despite the initial selection of items with a low rate of endorsement, 
3 of the items had endorsement rates of greater than 50% in the present sample. The SAS 
correlated 0.50 with the perceptual aberration scale, 0.47 with the magical ideation scale, 0.45 
with the revised social anhedonia scale, and 0.18 with the physical anhedonia scale (all 
correlations, p < 0.001). The intraclass correlation for the 9-week test-retest reliability was 0.74, 
p < 0.001. 
 
 A 2 × 2 (gender × ethnicity) ANOVA was computed on the total SAS score. Neither the main 
effect for gender, F(1,1794) = 0.26, Cohen's d = 0.02, nor the ethnicity × gender interaction, 
F(1,1794) = 0.34, was significant. The main effect for ethnicity, was significant, F(1,1794) = 
8.93, p < 0.01, d = 0.17, with African Americans (M = 7.09, SD = 4.20) exceeding whites (M = 
6.34, SD = 4.40). However, these findings should be interpreted cautiously given the sample size 
and small effect size. 
  
Interview Study 
 Table 2 presents comparisons of the schizotypal ambivalence and control groups on measures of 
psychopathology and overall adjustment. The ambivalence group exceeded the control group on 
ratings of psychotic-like, negative, schizotypal, schizoid, and paranoid symptoms, and evidenced 
poorer overall adjustment as assessed by the GAS. The ambivalence group demonstrated a trend 
toward more drug use, but the groups did not differ on ratings of alcohol use or on alcohol or 
drug impairment (the mean ratings reflected minimal use and impairment in both groups). Note 
that results were not presented separately by gender and ethnic group in Table 2 because 
inclusion of gender and ethnicity did not produce any substantive changes in the results. All of 
the t-tests comparisons were recomputed as multiple regression analyses with gender and 
ethnicity entered at the first step and group membership entered at the second step. The removal 
of the variance associated with gender and ethnicity did not change the significance of any of the 
group comparisons reported in Table 2. The groups did not differ significantly on the proportion 
of participants with major depressive episodes (Fisher exact test = 0.20), and none of the 
participants had experienced a manic episode. 
 
 Table 2   
 
 
None of the participants met criteria for a psychotic disorder at the time of the assessment. 
However, 1 schizotypal ambivalence group member qualified for a diagnosis of paranoid 
personality disorder. None of the other participants met criteria for a schizophrenia-spectrum 
disorder. 
 
  
DISCUSSION 
 In his chapter entitled, “The Fundamental Symptoms,” Bleuler (1911/1950) argued that 
“ambivalence is such an immediate consequence of the schizophrenic association disturbance 
that its complete absence appears highly improbable” (p. 53). Fifty years later, Meehl (1962) 
incorporated ambivalence as one of the core features of his model of schizotypy. However, aside 
from these notable inclusions, and the work by Raulin et al., the construct of ambivalence has 
been largely ignored in the experimental and developmental psychopathology literature. A recent 
literature search produced approximately 2500 citations containing the term ambivalence. 
However, only about 100 of these publications involved schizophrenia and related conditions 
and fewer than 1 dozen involved empirical studies of ambivalence in schizophrenic or 
schizotypic individuals. This raises the obvious questions of what did 2 of the preeminent 
thinkers in psychopathology find so compelling about the construct and why has it been so 
readily dismissed by the majority of psychopathology researchers? In other words, how do we 
reconcile the theoretical emphasis with the relative empirical disinterest? 
 
 Bleuler (1911/1950) recognized 3 subtypes of ambivalence (ambivalence of affect, will, and 
intellect). The ambivalence measured by the SAS is what Bleuler call ambivalence of affect. 
Bleuler's ambivalence of intellect is very close to our current concept of thought disorder. 
Bleuler viewed disordered thoughts and disordered emotions as similar phenomena, a view that 
is consistent with some current theories in neuroscience (e.g., Minsky, 2006). Bleuler argued that 
each of these subtypes of ambivalence resulted from a disruption of associative threads, 
suggesting that “the schizophrenic, with his weakened associative linkings does not necessarily 
bring the different aspects of a problem together” (p 374). Meehl (1989) viewed hypohedonia 
and ambivalence as resulting from a combination of neurodevelopmental deficits and aversive 
drift (resulting in large part from negative social learning). The everyday experience of 
ambivalence in healthy individuals (experienced as indecision or relatively normal vacillation in 
feelings and interests) probably has little in common with the clinical ambivalence first described 
by Bleuler. Bleuler's description of ambivalence is so dramatic that it borders on thought disorder 
and appears well outside the range of normal experience. However, the ubiquitous nature of 
normal ambivalent tendencies has likely contributed to the difficulty of rigorously identifying its 
clinical counterpart. As noted above, the problem of adequately operationalizing ambivalence 
has clearly worked against its formal study. Raulin recognized and attempted to address these 
shortcomings with the Intense Ambivalence Scale and later the SAS. Both of these measures 
seem to be psychometrically sound measures of ambivalence; however, the SAS seems to be 
especially promising for the assessment of the type of ambivalence that is related to 
schizophrenia and schizotypy. 
  
The present findings indicate that psychometrically identified ambivalence is associated with 
schizophrenic-like psychopathology in a nonclinical sample of young adults [over-and-above the 
preliminary work by Kwapil et al. (2000)]. Furthermore, unlike the earlier findings for the 
Intense Ambivalence Scale, the SAS was not broadly associated with psychopathology, but 
much more strongly related to schizophrenic-like impairment. Specifically, the effect sizes were 
in the medium to large range for measures of schizophrenia-spectrum psychopathology and 
impairment, but only in the small range for other forms of psychopathology. 
  
The last 20 years have seen an increasing focus on Bleuler's notion that negative symptoms of 
schizophrenia represent the fundamental disturbance in the disorder (e.g., Andreasen, 1990; 
Blanchard and Cohen, 2006; Faraone et al., 2001; Keefe et al., 1992; Lenzenweger and Dworkin, 
1996). Notably, the SAS group had elevated scores on measures of negative symptoms (e.g., the 
negative symptom manual and the schizoid dimensional score). Interestingly, the SAS correlated 
moderately with the perceptual aberration and magical ideation scales (measures of positive 
symptom schizotypy) and the revised social anhedonia scale (a measure of negative symptom 
schizotypy). All 3 of these screening measures were found to identify risk for the development of 
schizophrenia-spectrum disorders in nonpsychotic college students and the combination of the 
magical ideation scale and revised social anhedonia scales seemed to be an especially potent 
predictor of psychotic illness (Chapman et al., 1994; Kwapil, 1998). The SAS had only a modest 
correlation with the physical anhedonia scale—a measure that has not been an effective predictor 
of the development of spectrum disorders in college samples. The present findings indicate that 
ambivalence tapped by the SAS is associated with both positive and negative schizotypy. 
However, future investigations should examine the extent to which ambivalence may be better 
conceptualized as a separate dimension of schizotypy, as well as the extent to which it maps onto 
other putative dimensions of the construct (e.g., Claridge et al., 1996 social anxiety/cognitive 
disorganization factor). 
  
Given the solid psychometric properties of the scale and its correlations with proven 
psychometric inventories, it seems that the 19-item SAS provides a brief and effective method of 
initial screening for schizotypy. Obviously, prospective studies are required to determine the 
predictive validity of the SAS. Furthermore, the specificity of the scale will need more empirical 
evaluation. Specifically, future studies should examine the relationship of the measure with 
borderline personality traits, given the central role that ambivalence plays in formulation of this 
disorder. 
 
The employment of the SAS implicitly raises questions regarding the utility of the psychometric 
high-risk method for identifying individuals at risk for schizophrenia-spectrum disorders and for 
enhancing our understanding of the etiology and development of such disorders. One line of 
argument suggests that psychometric approaches may not be effective in the study of low base-
rate conditions such as schizophrenia. However, several lines of evidence suggest that the 
psychometric screening approach is a viable research method (e.g., Chapman et al., 1995; Edell, 
1995; Fernandes and Miller, 1995; Lenzenweger, 1998). The study of schizotypy (and the 
etiology and development of schizophrenia) is hampered by the lack of a gold standard (other 
than the development of full-blown schizophrenia). Although Lenzenweger et al. (2003) caution 
that psychometric screening inventories identify an admixture of schizotypes and 
nonschizotypes, these measures seem to identify meaningful variance related to schizotypy. 
Furthermore, these measures work especially well in conjunction with interview and laboratory 
measures of schizotypy and appear to be promising adjuncts for use in high-risk samples 
identified by consanguinity or clinical features. 
 
 The SAS provides a reliable and brief self-report inventory that seems promising as a research 
measure of 1 facet of schizotypy and schizophrenia. The questionnaire is not presently 
recommended for applied use because of the lack of research conducted with clinical samples. 
The results of the present study justify further use of the measure including development of 
norms with different demographic groups and the assessment of the predictive validity of the 
questionnaire. Furthermore, the present findings, in conjunction with findings for the Intense 
Ambivalence Scale, suggest that further study of the construct of ambivalence and its 
relationship to psychopathology is warranted. 
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